Summary Carcinoembryonic antigen (CEA) is one of the most important tumour markers in the management of human carcinoma, including lung cancer. So far, however, because of the nonspecificity of anti-CEA antibodies, it remains unclear whether the experimental measurements of CEA expression really reflect genuine CEA. In normal lung, nonspecific cross reacting antigen (NCA) has been described as a major component of CEA-related antigens. Recently isolated CEA and NCA cDNA clones enabled us to analyse CEA and NCA expression of in vivo tumour specimens and tumour cell lines at mRNA levels. NCA-specific mRNA (but not CEA-specific mRNA) was detected in all normal lung tissues examined. Of 21 lung cancer tissue specimens, nine expressed both NCA and CEA and five expressed only NCA. Of 16 tumour cell lines, two expressed only NCA and one expressed both NCA and CEA, although its level of CEA mRNA was weaker than that of NCA mRNA. Therefore, CEA-related mRNA expression was always accompanied by NCA mRNA expression; there were no cases of CEA mRNA expression alone. These findings suggest that NCA is a major member of the CEA-related gene family expressed in lung cancer.
Carcinoembryonic antigen (CEA), which was first described in 1965 as a colon tumour-specific antigen (Gold & Freedman, 1965) , is an important clinical marker of lung cancer in serum (Gail et al., 1988) , pleural effusion (Booth et al., 1977; Rittgers et al., 1978) and bronchoalveolar lavage fluid (BALF) (Lemarie et al., 1980; Goldstein et al., 1985) . The CEA concentrations in serum (Stevens & Mackay, 1973) and BALF (Merrill et al., 1981) of smokers are higher than those of nonsmokers, and patients with idiopathic pulmonary fibrosis demonstrate a high level of CEA in BALF (Takahashi et al., 1985) . These analyses were made by anti-CEA antibodies. However, some anti-CEA antibodies, especially polyclonal antibodies, also react with nonspecific crossreacting antigen (NCA), a CEA-related glycoprotein and a major component of the CEA family in the lung (von Kleist et al., 1972; Mach & Pusztaszeri, 1972) . As far as we know, the target of these antibodies was so-called CEA, a compound of genuine CEA and NCA, and there has been little discussion about the relevance of NCA, especially at the mRNA level.
Recently, CEA (Oikawa et al., 1987a; Zimmermann et al., 1987; Kamarck et al., 1987; Beauchemin et al., 1987) and NCA (Oikawa et al., 1987b; Tawaragi et al., 1988; Neumaier et al., 1988) cDNA clones were isolated and characterised. DNA analysis indicated that both of them are in the immunoglobulin superfamily (Oikawa et al., 1987c; Paxton et al., 1987) . The development of CEA and NCA-specific DNA probes enabled us to discriminate the expression of CEA and NCA at the mRNA level. In this paper, we describe various patterns of CEA and NCA mRNA expression in lung cancer cell lines and in vivo specimens.
at Nagoya University Hospital, Nagoya, Japan. Cancer types are listed in Table I. Cell lines Lung cancer cell lines A549 (adenocarcinoma), RERF-LC-MA (small cell), RERF-LC-MS (adenocarcinoma), SBC-2 (small cell), SBC-3 (small cell), EBC-1 (squamous cell), and PC-3 (adenocarcinoma) and stomach cancer cell line Kato III were obtained from the Japanese Cancer Research Resources Bank. Lung cancer cell lines 76, 67, 49, 177, 48 (small cell), SK-LC-4, 10 (adenocarcinoma) and Calu 6 (large cell) were obtained from Aichi Cancer Center (Dr T. Takahashi), Nagoya, Japan. Chinese hamster ovary (CHO) transformants expressing only CEA or NCA were established as previously described (Oikawa et al., 1989) . Each cell line was cultured in RPMI 1640 medium supplemented with 10% foetal calf serum.
DNA probe The CEA DNA probe, which hybridised with the 4.2 kb, 3.5kb (CEA) and 2.9kb (NCA) mRNAs, is a PvuII-digested DNA fragment of the pCEA 55-2 clone, CEA3 (Sato et al., 1988) (Figure 1 ). The EcoRI-digested DNA fragment of the 3'-untranslated region of NCA clone 15 (Tawaragi et al., 1988) was used as the NCA-specific DNA probe; it hybridised with the 2.9kb (NCA) mRNA (Figure 1) . Human ,-actin probe (Nakajima-Tijima et al., 1985) was used as an internal control.
Materials and methods
Tumour and nontumour specimens from lung cancer patients Twenty-one lung cancer tissue specimens and six normal lung tissue specimens were obtained from fresh surgical specimens DNA primer A pair of DNA primers, 5'-GACAGCTTTTCCCAAGA-TGT-3' (primer a) and 5'-AGTCTAGAAGTCCAACT-CTG-3' (primer b), was used to amplify the 303-bp NCA-specific fragment of the 3'-untranslated region of NCA mRNA. The position of the primer is shown in Figure 1 .
RNA isolation and Northern blot analysis Total RNA was extracted from each cell line and lung tissue specimen following the methods described in the literature (Chomczynski & Sacchi, 1987 tat sections to be observed by light microscopy were treated with 100% methanol containing 0.03% hydrogen peroxidase to inactivate endogenous peroxidase. The indirect horseradish peroxidase-labelled antibody method was used for the immunological reaction, as previously described (Nagura et al., 1986; Yamamoto et al., 1988) . Briefly, the procedure involved successive incubations with or without the first antibody in optimal dilutions for 12 h at 4°C and the second antibody for 6 h at 4°C. Sections were then treated with 0.25% diaminobenzidine (DAB) solution containing 0.01 M sodium azide and 0.01 M hydrogen peroxide and counterstained with methyl green. 
Results
Confirmation of specificity of NCA probe
Northern hybridisation analysis was used to confirm the specificity of the NCA probe. We analysed the thymuses of CEA-transgenic mice established by us (Hasegawa et al., 199 1) and the Kato III tumour cell line. When we used the CEA probe, we could detect CEA mRNA in the transgenic mice's thymuses (data not shown) as mentioned before (Hasegawa et al., 1991) and 4.2, 3.5, and 2.9kb mRNAs in Kato III (Figure 2 ). However, when we used the NCA probe, we could not detect any mRNA in the CEA-transgenic mice's thymuses or in normal B6 mice's thymuses (Figure 3 ), but we could detect one band (2.9kb) of mRNA in Kato III ( Figure  3 ). The CEA probe we used hybridised not only with CEA but also with NCA mRNA, because the probe recognised the NCA coding region that has very high homology with the CEA coding region. From these results, we confirmed that the CEA probe hybridised with CEA (4.2, 3.5 kb) and NCA (2.9kb) mRNAs and that the NCA probe hybridised only with NCA (2.9kb) mRNA.
Expression of NCA and CEA mRNAs in lung cancer cell lines Cell lines A549 and PC3 expressed 2.9kb NCA mRNA, but not 4.2 or 3.5kb CEA mRNAs when CEA (Figure 2 ) and NCA ( Figure 3 ) probes were used. Cell line SK-LC-10 expressed 4.2, 3.5, and 2.9kb mRNAs (Figure 2) , although the 4.2 and 3.5kb mRNAs were weaker than the 2.9kb mRNA. The other cell lines expressed neither CEA nor NCA mRNA (Figures 2, 3) . From these results, we concluded that if the CEA-related genes were expressed in the lung, they always include NCA, but only occasionally include CEA. The NCA-specific probe confirmed these results ( Figure 5 ). The analyses of cell lines and in vivo specimen are summarised in Tables II and  III. Detection of NCA mRNA transcripts using RT-PCR To confirm the negative expression of NCA in lung cancer cell lines and tissue specimens, we carried out RT-PCR. As shown in Figure 6a , we could clearly detect NCA PCR products in cell lines A549, PC-3, and SBC-2 and weak bands in cell lines EBC-1 and RERF-LC-MS. Figure 7a , the stained cells in noncancerous lung tissues of patient 3 were mostly epithelial cells; stromal tissues and muscle were not stained. Figure 7b shows an example of the lung cancer tissue (again, patient 3). In addition, as shown in Figure 8 , cell line A549, which expressed only NCA mRNA, reacted to the anti-CEA polyclonal antibody (Figure 8b) as did cell line Kato III, which expressed both NCA and CEA mRNAs (Figure 8a ). Cell line SBC-2, which expressed a very low level of NCA detected only by sensitive RT-PCR, had almost no reactivity with the anti-CEA polyclonal antibody (Figure 8c ).
Our final analysis was a Western blot. As shown in Figure  9 , we clearly detected a 50-to 130-kDa protein in cell line A549 and in the NCA-transformant CHO cell line. In cell lines PC3 and Kato III we could detect both CEA and NCA proteins. In cell lines SBC-2 and A549 we could detect a 200-kDa band, which might have been a CEA band, weakly. In cell lines EBC-1 and RERF-LC-MS, we could not detect a protein band, although we could detect NCA RT-PCR products.
Discussion
CEA is one of the most important tumour markers in patients with cancer, including lung cancer. In clinical analysis polyclonal antibodies are usually used, which also react with non-CEA products. Even if we analyse CEA expression with monoclonal antibodies, there are at least five groups of antibodies that recognise different epitopes (NCAcommon, normal foecal crossreacting antigen-common, nor- mal foecal antigen-I-common, heterogenous, and CEAdistinctive antibodies) (Kuroki et al., 1987) . It is still difficult to use NCA-specific antibodies that do not react with the CEA molecule. Moreover, there is a possibility that some monoclonal antibodies could not react with the CEA or NCA molecules of cells in which we detected CEA or NCA mRNA because of glycosylation or three-dimensional confor- sufficient in lung diseases. If genuine CEA is elevated in some lung diseases, it is possible that NCA is also elevated in those diseases.
The recent development of an NCA-specific DNA probe enabled us to study these problems. We examined CEA mRNA and NCA mRNA expression separately by Northern We carried out RT-PCR analysis to confirm the results of the Northern blot analysis, because the mRNA-positive percent was lower than that we expected. We detected NCA PCR products in some cancer cell lines in which we could not detect NCA mRNA by Northern blot analysis. In cell line A549 the results of Northern blot, RT-PCR, and Western blot were well correlated. But the molecular size of the protein expressed by cell lines PC-3 and SBC-2 was not correlated with the Northern blot and RT-PCR analyses. One possibility is that there might exist very small amounts of CEA mRNA in both cell lines. Each CEA mRNA might be translated to protein, but the NCA mRNA in cell line SBC-2 might not be translated to protein. Another possibility is that anti-CEA polyclonal antibodies react with products other than CEA and NCA. We detected NCA PCR products in all tissue specimens examined. One explanation is that all lung cancers express NCA at very low levels. Another is that normal lung tissues that express NCA are contaminated.
Finally, CEA and NCA have been described as cell-cell adhesion molecules (Benchimol et al., 1989; Oikawa et al., 1989) , and it is possible that they play an important role in cancer metastasis. In addition, the high lysability by LAK cells of colon carcinoma cells resistant to doxorubicin has been associated with NCA and not CEA (Rivoltini et al., 1991) . Therefore, the assessment of CEA and NCA expression in lung cancers may be important in determining the prognosis of lung cancer patients.
In conclusion, lung cancer cells fall into three different types according to their CEA and/or NCA expression by Northern blot analysis. It is important that CEA and NCA are estimated separately in lung cancers at the mRNA level or the protein level.
